| Literature DB >> 36090841 |
Audrey Butty1, Nolwenn Bühler1,2, Jérôme Pasquier1, Julien Dupraz1, Vincent Faivre1, Sandrine Estoppey1, Cloé Rawlinson1, Semira Gonseth Nusslé1, Murielle Bochud1, Valérie D'Acremont1,3.
Abstract
Objectives: We quantified adherence to COVID-19 preventive measures and explored associated factors, after the first and during the second Swiss epidemic waves.Entities:
Keywords: COVID-19; SARS-CoV-2; adherence; population-based sample; preventive behaviours; preventive measures; representative
Mesh:
Year: 2022 PMID: 36090841 PMCID: PMC9453818 DOI: 10.3389/ijph.2022.1605048
Source DB: PubMed Journal: Int J Public Health ISSN: 1661-8556 Impact factor: 5.100
FIGURE 1Participation flow chart (SérocoViD study, Vaud, Switzerland, 2020).
Participants’ characteristics at baseline and follow-up (SérocoViD study, Vaud, Switzerland, 2020).
| Baseline | Follow-up | |
|---|---|---|
| Number of participants | 494 (100.0) | 410 (100.0) |
| Gender | ||
| Women | 266 (54.5) | 220 (54.1) |
| Men | 228 (45.5) | 190 (45.9) |
| Others | None | None |
| Age at baseline | ||
| 15–24 years | 95 (11.4) | 77 (11.3) |
| 25–64 years | 221 (68.6) | 187 (68.7) |
| 65+ years | 178 (20.0) | 146 (20.0) |
| Education | ||
| Lower secondary or less | 60 (8.5) | 76 (10.0) |
| Upper secondary | 235 (42.0) | 151 (35.7) |
| Tertiary | 197 (49.6) | 182 (54.4) |
| Smoking status | ||
| Non smokers | 277 (55.6) | 252 (60.7) |
| Ex-smokers | 107 (19.8) | 87 (20.7) |
| Current smokers | 109 (24.6) | 71 (18.7) |
| Weight status | ||
| Normal or underweight | 283 (55.8) | 230 (54.8) |
| Overweight or obese | 207 (44.2) | 178 (45.2) |
| Chronic disease | ||
| None | 308 (68.7) | 289 (74.8) |
| One or more | 171 (31.3) | 121 (25.2) |
| Previous confirmed COVID-19 episode | ||
| None | 493 (99.9) | 350 (82.8) |
| One or more | 1 (0.1) | 60 (17.2) |
| Respect of simple hygiene rules | ||
| Yes, always | 392 (79.7) | 301 (73.0) |
| Not always | 96 (20.3) | 109 (27.0) |
| Respect of social distancing rules | ||
| Yes, always | 306 (60.0) | 237 (60.1) |
| Not always | 183 (40.0) | 172 (39.9) |
| Wearing a mask in public | ||
| Yes, always | 81 (13.3) | 238 (55.5) |
| Not always | 409 (86.7) | 172 (44.5) |
| Serological test | ||
| Positive | 47 (10.5) | 57 (16.9) |
| Negative | 447 (89.5) | 353 (83.1) |
Baseline: For adults (>20 years), highest level of education. For adolescents (15–20 years), current education. Follow-up: For adults (>20 years) and adolescents (15–20 years), highest level of education.
Baseline: For adults, presence of hypertension, diabetes, cardiovascular disease, respiratory disease, immunity deficiency, cancer, or other chronic disease. For adolescents, presence of a non-specified chronic disease. Follow-up: For adults and adolescents, presence of hypertension, diabetes, cardiovascular disease, respiratory disease, immunity deficiency, cancer, or other chronic disease.
Baseline: Presence of a previous positive PCR test result. Follow-up: Presence of a previous positive PCR or rapid antigen or baseline serological test result.
Baseline: “Yes.” Follow-up: “Always”.
Baseline: “Mostly yes,” “Mostly no,” or “No.” Follow-up: “Frequently,” “Occasionally,” “Very rare,” or “Never.”
Baseline: “Yes, always.” Follow-up: “Always.”
Baseline: “Yes, sometimes,” or “No.” Follow-up: “Frequently,” “Occasionally,” “Very rare,” or “Never.”
Presented as number with percentage.
FIGURE 2Adherence to preventive measures according to gender at baseline and follow-up (SérocoViD study, Vaud, Switzerland, 2020).
FIGURE 3Adherence to preventive measures according to age at baseline and follow-up (SérocoViD study, Vaud, Switzerland, 2020).
FIGURE 4Adherence to preventive measures according to education level at baseline and follow-up (SérocoViD study, Vaud, Switzerland, 2020).
Multivariable analysis of participants’ adherence to preventive measures at baseline and follow-up (SérocoViD study, Vaud, Switzerland, 2020).
| Respect of simple hygiene rules | Respect of social distancing rules | Wearing a mask | ||||
|---|---|---|---|---|---|---|
| Baseline (N = 474) | Follow-up (N = 409) | Baseline (N = 475) | Follow-up (N = 408) | Baseline (N = 473) | Follow-up (N = 409) | |
| Covariates | aOR (95% CI) | aOR (95% CI) | aOR (95% CI) | aOR (95% CI) | aOR (95% CI) | aOR (95% CI) |
| Gender | ||||||
| Women | reference | reference | reference | reference | reference | reference |
| Men | 0.56 (0.33; 0.96)* | 0.30 (0.17; 0.51)*** | 0.82 (0.52; 1.29) | 1.03 (0.64; 1.67) | 0.73 (0.40; 1.33) | 0.55 (0.35; 0.87)** |
| Age at baseline | ||||||
| 15–24 years | 1.04 (0.51; 2.09) | 0.51 (0.22; 1.23) | 0.29 (0.16; 0.55)*** | 0.33 (0.14; 0.79)** | 1.03 (0.35; 3.03) | 1.14 (0.52; 2.51) |
| 25–64 years | reference | reference | reference | reference | reference | reference |
| 65+ years | 1.66 (0.89; 3.08) | 1.31 (0.72; 2.42) | 2.39 (1.42; 4.00)*** | 1.17 (0.70; 1.96) | 2.63 (1.40; 4.94)** | 1.34 (0.82; 2.19) |
| Education | ||||||
| Lower secondary or less | reference | reference | reference | reference | reference | reference |
| Upper secondary | 1.05 (0.42; 2.65) | 0.73 (0.31; 1.71) | 0.93 (0.43; 2.02) | 1.47 (0.68; 3.15) | 0.72 (0.32; 1.64) | 1.00 (0.48; 2.11) |
| Tertiary | 1.09 (0.41; 2.90) | 0.67 (0.28; 1.58) | 0.76 (0.34; 1.68) | 2.05 (0.95; 4.44) | 0.50 (0.20; 1.25) | 0.89 (0.42; 1.87) |
| Chronic disease | ||||||
| None | reference | reference | reference | reference | reference | reference |
| One or more | 1.13 (0.62; 2.06) | 1.56 (0.76; 3.19) | 1.51 (0.88; 2.59) | 1.93 (1.09; 3.43) | 2.36 (1.22; 4.55)** | 1.90 (1.08; 3.32) |
Baseline: For adults (>20 years), highest level of education. For adolescents (15–20 years), current education. Follow-up: For adults (>20 years) and adolescents (15–20 years), highest level of education.
Baseline: For adults, presence of hypertension, diabetes, cardiovascular disease, respiratory disease, immunity deficiency, cancer, or other chronic disease. For adolescents, presence of a non-specified chronic disease. Follow-up: For adults and adolescents, presence of hypertension, diabetes, cardiovascular disease, respiratory disease, immunity deficiency, cancer, or other chronic disease.
*p-value ≤ 0.05 **p-value ≤ 0.01 ***p-value ≤ 0.001.
Adjusted odds ratios come from a multivariable logistic regression analysis including gender, age, education and chronic disease as covariables. aOR, adjusted odds ratio. N, number of participants. CI, confidence interval.